Supernus Pharmaceuticals | SUPN - Passifs Courants





Passifs Courants Changement Date
Abbott USD 16.15B 1.66B 2026-09
ANI Pharmaceuticals USD 328.72M 45.06M 2026-09
Aurora Cannabis CAD 73.43M 6.5M 2026-06
Bristol-Myers Squibb USD 18.75B 94M 2026-09
Canopy Growth CAD 166.75M 8.31M 2026-06
Cara Therapeutics USD 8.08M 3.18M 2026-09
Corcept Therapeutics USD 177.68M 23.87M 2026-09
Eisai JPY 371.5B 22.14B 2026-09
Eli Lilly USD 47B 745M 2026-09
Novo Nordisk DKK 239.08B 13.92B 2026-06
Pacira USD 126.1M 4.08M 2026-09
Perrigo USD 1.02B 34.4M 2026-09
Pfizer USD 31.73B 920M 2026-09
Supernus Pharmaceuticals USD 285.4M 61.98M 2026-09
United Therapeutics USD 624.3M 16.5M 2026-09
Xeris Pharmaceuticals USD 134.48M 55.09M 2026-09